BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16984986)

  • 1. Impact of type 2 diabetes on myocardial insulin sensitivity to glucose uptake and perfusion in patients with coronary artery disease.
    Søndergaard HM; Bøttcher M; Marie Madsen M; Schmitz O; Hansen SB; Nielsen TT; Bøtker HE
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4854-61. PubMed ID: 16984986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.
    Paternostro G; Camici PG; Lammerstma AA; Marinho N; Baliga RR; Kooner JS; Radda GK; Ferrannini E
    J Clin Invest; 1996 Nov; 98(9):2094-9. PubMed ID: 8903329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance.
    Iozzo P; Chareonthaitawee P; Dutka D; Betteridge DJ; Ferrannini E; Camici PG
    Diabetes; 2002 Oct; 51(10):3020-4. PubMed ID: 12351442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM.
    Utriainen T; Takala T; Luotolahti M; Rönnemaa T; Laine H; Ruotsalainen U; Haaparanta M; Nuutila P; Yki-Järvinen H
    Diabetologia; 1998 May; 41(5):555-9. PubMed ID: 9628273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
    Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
    J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.
    Rijzewijk LJ; Jonker JT; van der Meer RW; Lubberink M; de Jong HW; Romijn JA; Bax JJ; de Roos A; Heine RJ; Twisk JW; Windhorst AD; Lammertsma AA; Smit JW; Diamant M; Lamb HJ
    J Am Coll Cardiol; 2010 Jul; 56(3):225-33. PubMed ID: 20620743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease.
    Dutka DP; Pitt M; Pagano D; Mongillo M; Gathercole D; Bonser RS; Camici PG
    J Am Coll Cardiol; 2006 Dec; 48(11):2225-31. PubMed ID: 17161251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin.
    Masi S; Lautamäki R; Guiducci L; Di Cecco P; Porciello C; Pardini S; Morales MA; Chubuchny V; Salvadori PA; Emdin M; Sironi AM; Knuuti J; Neglia D; Nuutila P; Ferrannini E; Iozzo P
    Diabetologia; 2012 Sep; 55(9):2494-500. PubMed ID: 22752026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension.
    Yokoyama I; Ohtake T; Momomura S; Yonekura K; Yamada N; Nishikawa J; Sasaki Y; Omata M
    J Nucl Med; 1998 May; 39(5):884-9. PubMed ID: 9591594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.
    Laine H; Yki-Jarvinen H; Kirvela O; Tolvanen T; Raitakari M; Solin O; Haaparanta M; Knuuti J; Nuutila P
    J Clin Invest; 1998 Mar; 101(5):1156-62. PubMed ID: 9486987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-stimulated myocardial glucose uptake and the relation to perfusion and the nitric oxide system.
    Søndergaard HM; Bøttcher M; Schmitz O; Nielsen TT; Bøtker HE
    J Vasc Res; 2004; 41(1):38-45. PubMed ID: 14726631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise training improves insulin stimulated skeletal muscle glucose uptake independent of changes in perfusion in patients with dilated cardiomyopathy.
    Kemppainen J; Stolen K; Kalliokoski KK; Salo T; Karanko H; Viljanen T; Airaksinen J; Nuutila P; Knuuti J
    J Card Fail; 2003 Aug; 9(4):286-95. PubMed ID: 13680549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease.
    Mäki M; Nuutila P; Laine H; Voipio-Pulkki LM; Haaparanta M; Solin O; Knuuti JM
    Diabetes; 1997 Sep; 46(9):1491-6. PubMed ID: 9287051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low whole-body insulin sensitivity in patients with ischaemic heart disease is associated with impaired myocardial glucose uptake predictive of poor outcome after revascularisation.
    Kofoed KF; Carstensen S; Hove JD; Freiberg J; Bangsgaard R; Holm S; Rabøl A; Hesse B; Arendrup H; Kelbaek H
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):991-8. PubMed ID: 12173011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease: a 16-week randomized, double-blind, placebo-controlled study.
    Lautamäki R; Airaksinen KE; Seppänen M; Toikka J; Luotolahti M; Ball E; Borra R; Härkönen R; Iozzo P; Stewart M; Knuuti J; Nuutila P
    Diabetes; 2005 Sep; 54(9):2787-94. PubMed ID: 16123370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-induced increment of coronary flow reserve is not abolished by dexamethasone in healthy young men.
    Laine H; Nuutila P; Luotolahti M; Meyer C; Elomaa T; Koskinen P; Rönnemaa T; Knuuti J
    J Clin Endocrinol Metab; 2000 May; 85(5):1868-73. PubMed ID: 10843167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.
    Lautamäki R; Borra R; Iozzo P; Komu M; Lehtimäki T; Salmi M; Jalkanen S; Airaksinen KE; Knuuti J; Parkkola R; Nuutila P
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E282-90. PubMed ID: 16478772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
    Jaumdally RJ; Lip GY; Patel JV; MacFadyen RJ; Varma C
    J Intern Med; 2009 Jun; 265(6):689-97. PubMed ID: 19226374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone.
    Hällsten K; Virtanen KA; Lönnqvist F; Janatuinen T; Turiceanu M; Rönnemaa T; Viikari J; Lehtimäki T; Knuuti J; Nuutila P
    Diabet Med; 2004 Dec; 21(12):1280-7. PubMed ID: 15569129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial perfusion and glucose uptake coupling in CAD patients.
    Mazzadi AN; Croisille P; André-Fouët X; Fol S; Duisit J; Ovize M; Comar D; Janier MF
    Int J Cardiovasc Imaging; 2003 Oct; 19(5):389-99. PubMed ID: 14609188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.